Is Filgrastim-sndz Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use Filgrastim-sndz? Is Filgrastim-sndz safe for nursing mother and child? Does Filgrastim-sndz extracts into breast milk? Does Filgrastim-sndz has any long term or short term side effects on infants? Can Filgrastim-sndz influence milk supply or can Filgrastim-sndz decrease milk supply in lactating mothers?
Filgrastim-sndz lactation summary
- DrLact safety Score for Filgrastim-sndz is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of Filgrastim-sndz is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that Filgrastim-sndz does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of Filgrastim-sndz safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About Filgrastim-sndz usage in lactation
Non-glycosylated stimulating factor of granulocyte colonies (G-CSF) which is obtained by recombinant technology.The naturally occurring product is found in breast milk. A very high molecular weight explains the insignificant or no excretion into milk that has been observed both with Lenograstim and Filgrastim-sndz. Its low oral bioavailability hampers absorption into infant plasma from the breast milk ingested, as for their proteic nature it is degraded in the gastrointestinal tract, not being absorbed. Filgrastim-sndz is not absorbed by the infant's gut even during the neonatal period or prematurity. The granulocyte colony-stimulating factor has been used in premature newborns, both on prevention and treatment of neonatal sepsis and/or necrotizing enterocolitis without adverse effects being observed among treated infants. The bovine G-CSF is found in the usual diet of meat eaters.
Answer by DrLact: About Filgrastim-sndz usage in lactation
Filgrastim-sndz in the pharmaceutical name for granulocyte colony-stimulating factor (G-CSF). PegFilgrastim-sndz is the long-acting form of Filgrastim-sndz. The excretion of exogenous G-CSF into breastmilk or its effects on breastfed infants have not been well studied. Limited data indicate that Filgrastim-sndz and a similar G-CSF product, lenograstim, are poorly excreted into breastmilk and are undetectable by 3 days after an injection. Some authors recommend withholding breastfeeding for this period of time.[1] However, Filgrastim-sndz has been safely given orally to neonates and is not orally absorbed by neonates, so any Filgrastim-sndz that is excreted into milk is unlikely to adversely affect the breastfed infant.
Filgrastim-sndz Side Effects in Breastfeeding
Published information on the effects of Filgrastim-sndz in breastmilk was not found as of the revision date. However, oral Filgrastim-sndz 20 mcg daily for 5 days has been given to preterm infants with stage I necrotizing enterocolitis (NEC). Filgrastim-sndz appeared to halt progression to more severe stages of NEC in this small study.[6]